Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra.

Literature DB >> 32637933

Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra.

Abstract

Entities: Chemical Disease

Keywords: Citation: İlgen U; Küçükşahin O. Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra. Arch Rheumatol 2020;35(1):149-150.

Year: 2019 PMID： 32637933 PMCID： PMC7322309 DOI： 10.5606/ArchRheumatol.2020.7378

Source DB: PubMed Journal: Arch Rheumatol ISSN： 2148-5046 Impact factor: 1.472

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

Review 1. Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation.

Authors: Takahiro Itamiya; Toshihiko Komai; Hiroko Kanda; Yasuo Nagafuchi; Hyangri Chang; Shota Shibata; Hiroyuki Ishiura; Hirofumi Shoda; Tatsushi Toda; Keishi Fujio
Journal: Clin Rheumatol Date: 2022-03-22 Impact factor: 2.980

1 in total